Page last updated: 2024-11-06

mitomycin and Coats Disease

mitomycin has been researched along with Coats Disease in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"The cases reported concern 5 eyes in four DEX-I IVI high-responder patients whose intraocular pressure (IOP) returned to normal after administration of a XEN gel stent with mitomycin subconjunctival injection, thus allowing the continued use of DEX-I which was the only therapeutic option for these patients."3.91XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases. ( Denis, P; Kodjikian, L; Mathis, T; Rezkallah, A, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rezkallah, A1
Mathis, T1
Denis, P1
Kodjikian, L1

Other Studies

1 other study available for mitomycin and Coats Disease

ArticleYear
XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases.
    Journal of glaucoma, 2019, Volume: 28, Issue:1

    Topics: Aged; Alkylating Agents; Dexamethasone; Drug Implants; Female; Glaucoma Drainage Implants; Glucocort

2019